Shanghai Junshi Biosciences Co Ltd (688180) — Capital Reinvestment Ratio
Latest as of March 2022:
0.17x
Shanghai Junshi Biosciences Co Ltd (688180) has a Capital Reinvestment Ratio of 0.17x as of March 2022, meaning it reinvests 0% of its operating cash flow (CN¥570.43 Million) in capital expenditures (CN¥97.07 Million). See cash generation quality of Shanghai Junshi Biosciences Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥570.43 Million
CNY
Capital Expenditures
CN¥97.07 Million
CNY
Data as of
Mar 2022
Most recent filing
Annual Capital Reinvestment Ratio for Shanghai Junshi Biosciences Co Ltd (None–None)
Year-by-year Capital Reinvestment Ratio for Shanghai Junshi Biosciences Co Ltd from None to None. For live market cap and broader valuation context, see Shanghai Junshi Biosciences Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow